Navigation Links
Digital Assent Expands Leadership Team to Address Rapidly Growing Demand for the PatientPad
Date:3/31/2011

ATLANTA, March 31, 2011 /PRNewswire/ -- Digital Assent has expanded its leadership team to meet the rapidly growing demand for its award-winning PatientPad® solution.  The PatientPad is a self-service patient check-in and education solution designed to automate the patient intake process and deliver targeted health information to interested patients while they wait. The company has added five key executives to its sales, business development, operations and product development teams.

"We've assembled an impressive team of experienced professionals to help our company deliver on the rapidly growing demand for self-service technology in the U.S. healthcare market," said Andrew Ibbotson, president and CEO of Digital Assent. "Given the massive push to convert to electronic health records and the exploding popularity of mobile touch-screen devices, we expected the PatientPad to be well-received by physicians and patients, but early demand for the PatientPad has outstripped our most optimistic expectations.  The market potential is huge, and we have the team needed to capitalize on it."

Market adoption of the PatientPad is being driven by David Schwickerath, the company's vice president of sales. With more than 30 years of successful technology sales and management experience, Schwickerath is responsible for the company's overall sales strategy and execution.  Prior to Digital Assent, Schwickerath served as vice president of worldwide sales for Lancope.  Before this, he served as senior vice president of sales for Borland Corporation, Starbase Corporation and Technology Builders, Inc.  Schwickerath has also served in executive sales management roles with Computer Associates, GE Software International and Automatic Data Processing, Inc.

Cynthia Foster recently joined Digital Assent as the inside sales manager.  As such, she will oversee a rapidly growing team of inside sales representatives. Foster comes to Digital Assent with more than 25 years of experience in sales, training and customer service. In the past, she served as inside sales manager for Sciele Pharma, Inc. as well as medical education manager for Visible Genetics; also, she held various sales and customer service roles at Fisher Scientific.

Beth Goetz, business development manager for Digital Assent, manages field sales operations and relationships with strategic partners.  Goetz has more than 13 years of experience in pharmaceutical and medical device sales. For the past eight years, Goetz focused exclusively on aesthetic sales. She has extensive experience selling in the aesthetic market and has relationships with aesthetic practices across the country. Her career began with Eli Lilly.

Whit Lanier, vice president of operations for Digital Assent, oversees all activities related to the rapid and successful deployment of the PatientPad to physician practices and is responsible for maintaining high customer satisfaction.  Lanier has a proven track record of building high-impact teams and previously held leadership positions at two other high-growth technology companies, Atlanta-based Silverpop and Berkeley HeartLab, Inc., an independent subsidiary of Celera Corp.  Lanier began his career with KPMG and Accenture and holds an MBA from the Kellogg School of Management.

Mark Conlin recently left American Express to join Digital Assent as chief software architect.  "Mark's experience processing and managing hundreds of terabytes of sensitive cardholder data will be extremely valuable as we continue to grow our PatientPad point-of-care network," commented Tim Collins, chief technology officer for Digital Assent.  Prior to American Express, Conlin served as software architect and product manager for ePipeline. Additionally, Conlin has held relevant technology leadership roles at Answerthink, Accenture and MCI Worldcom.

This announcement comes on the heels of Digital Assent closing a Series A round of equity financing led by Imlay Investments, Fulcrum Equity Partners and BLH Venture Partners. The funding allowed Digital Assent to launch a national sales and marketing campaign, grow its leadership team and workforce, and invest in ongoing research and development, all while preparing itself for a possible second round of financing to accelerate market adoption.

About Digital Assent

Founded in 2009, Digital Assent is a fast-growing healthcare technology company based in Atlanta.  The company's wireless touch-screen PatientPad® solution streamlines the patient check-in process and delivers targeted health information to interested patients while they sit in their doctor's waiting room or exam room. By automating patient intake, the PatientPad enables healthcare providers to collect patient information in a standard electronic format, more easily transition from paper to electronic health records, and improve the overall patient experience.  For more information about Digital Assent and the company's rapidly growing PatientPad point-of-care network, please visit www.digitalassent.com or www.patient-pad.com.


'/>"/>
SOURCE Digital Assent
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. ProUroCare Medical Completes Clinical Trial at Second Study Site Using Digital Prostate Imaging Technology
2. Verathon Introduces the GlideScope(R) Cobalt Advanced Video Laryngoscope (AVL); New Digital Technology Facilitates Quick Intubations
3. Escalon(R) Subsidiary Escalon Digital Solutions Announces Release of Web-Based AXIS(TM) Image Management System
4. Now Approved: Fujifilms FDR AcSelerate Direct Digital DR System
5. World Renowned Physician and Thought Leader Dr. Eric J. Topol to Highlight Digital Medicine Revolution at International CES 2010
6. Womens Digital Imaging Using DXA Total Body Fat Analysis to Help Patients in Weight Management and Fitness Programs
7. Frost & Sullivan to Speak at 2010 International Consumer Electronics Digital Health Summit
8. Varian Medical Systems to Highlight the Latest Digital Detectors, X-ray Tubes and Cancer Treatment Technology at the Radiological Society of North America (RSNA) Annual Meeting in Chicago
9. Waters SDMS Vision Publisher Now Certified Compliant with SAFE-BioPharma Digital Standard
10. Raytheon BBN Technologies Licenses Stereo Digital Mammography Technology to FUJIFILM Corporation
11. Volcano Receives FDA Clearance to Market the Eagle Eye(R) Platinum Digital IVUS Catheter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... LAKE OSWEGO, Ore. , Dec. 5, 2016 /PRNewswire/ ... in the BioInsight clinical study. The study evaluates the ... 2 insertion procedure in an office setting. ... ProMRI ® technology that is placed underneath a ... atrial fibrillation and syncope (fainting). Atrial fibrillation is a ...
(Date:12/5/2016)... and Gateway Health proudly announce a dynamic collaboration that will ... members with specific high risk needs. In an ... of consumers, Wellbridge combines technology and population expertise with a ... daily behaviors and lifestyle. ... , , "Dealing ...
(Date:12/5/2016)... PARSIPPANY, N.J. , Dec. 5, ... Sankyo) today announced preliminary safety and efficacy data ... investigational oral selective MDM2 inhibitor, suggesting that DS-3032 ... including relapsed/refractory acute myeloid leukemia (AML) and high-risk ... escalation part of the phase 1 study of DS-3032 ...
Breaking Medicine Technology:
(Date:12/5/2016)... ... 2016 , ... For many years, Andrew G. Zubinas has accumulated ... beauty of the Lithuanian language and its poetry inspired him in writing ... lyrically explores all aspects of a living, breathing forest where nothing ever stays the ...
(Date:12/5/2016)... Atlanta, GA (PRWEB) , ... ... ... information technology and security executive networking and relationship-marketing firm, announced today that ... for the 2017 Information Security Executive® (ISE®) Central Awards. , Awards include ...
(Date:12/5/2016)... Novato, CA (PRWEB) , ... December 05, 2016 ... ... company, has extended its partnership with leading global lifestyle design firm kathy ireland® ... , Worldwise® and kathy ireland® Worldwide entered into an exclusive licensing agreement three ...
(Date:12/5/2016)... ... December 05, 2016 , ... Progressive ... of L-Citrulline and glutathione to enhance production of nitric oxide (NO). , NitroGenesis ... shown to produce NO twice as effectively and sustains NO blood levels twice ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... announced that the company will provide alerting technology to Central Illinois Health ... awarded $1.7 million in federal funds as the sole sub-recipient participating with ...
Breaking Medicine News(10 mins):